FAQs - The Robert A. Winn Excellence in Clinical Trials Award Program

Q: Are US permanent residents (green card holders) eligible to apply for Winn CIPP?

[fusion_builder_container type="flex" hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" border_style="solid"][fusion_builder_row][fusion_builder_column type="1_1" type="1_1" background_position="left top" border_style="solid" border_position="all" spacing="yes" background_repeat="no-repeat" margin_top="0px" margin_bottom="0px" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" hover_type="none" min_height="" link=""][fusion_text] Yes, US citizens, US permanent residents, and students with Deferred Action for Childhood Arrivals (DACA) approval are all eligible to apply for Winn CIPP. Proof of status may be required upon acceptance. [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

Q: Do I need to be affiliated with a safety net hospital or community health clinic to be considered?

The scholar will need admitting rights to whatever institution that is associated with their mentor’s clinical trial.

Q: I am currently a clinician-researcher and dedicate a certain portion of my time to research and a certain portion to clinical care. Do I have to dedicate 40% of my full-time equivalent (FTE) to research only?

Yes, 40% of the scholar's FTE should be dedicated to research. If there are other research projects that already have a substantial amount of their time taken up, the scholar may not have time to participate in this program.

Q: What will the clinical trials training consist of? Will this be formal coursework (i.e., biostats, epidemiology, writing trials or grants), practical instruction on developing and running investigator-initiated trials and industry-sponsored trials, or a combination of the two?

The two-year Robert A. Winn Excellence in Clinical Trials: Community-oriented Clinical Trialist Training (Winn COCT Training) will be delivered in a variety of formats (e.g., didactic lectures, practical workshops, expert panels, and roundtable community discussions). Additionally, it will provide comprehensive training in clinical research design, funding, and implementation, and in community engagement methods and strategies. An intensive 4.5 day training in clinical research, designed and hosted by the American Association for Cancer Research (AACR), will precede and set the foundation for the Winn COCT Training.